Personalis Future Growth
Future criteria checks 2/6
Personalis is forecast to grow earnings and revenue by 37.2% and 21.9% per annum respectively. EPS is expected to grow by 42.8% per annum. Return on equity is forecast to be -49% in 3 years.
Key information
37.2%
Earnings growth rate
42.8%
EPS growth rate
| Life Sciences earnings growth | 16.6% |
| Revenue growth rate | 21.9% |
| Future return on equity | -49.0% |
| Analyst coverage | Good |
| Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower
Apr 19
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story
Mar 02Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story
Dec 18Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?
Dec 04Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely
Sep 04Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)
Apr 17The Prognosis For Personalis
Jun 16Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?
Jun 09Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?
Feb 17Personalis: Getting Personal Again
Feb 02Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?
Nov 11Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth
Oct 12We're Hopeful That Personalis (NASDAQ:PSNL) Will Use Its Cash Wisely
Jul 05Personalis: Market-Leading Immuno-Oncology Platform Drives Consistent Long-Term Growth
Jun 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 115 | -63 | N/A | N/A | 4 |
| 12/31/2025 | 85 | -73 | N/A | N/A | 6 |
| 12/31/2024 | 74 | -78 | N/A | N/A | 6 |
| 12/31/2023 | 73 | -108 | -67 | -56 | N/A |
| 9/30/2023 | 71 | -113 | -77 | -60 | N/A |
| 6/30/2023 | 67 | -110 | -95 | -58 | N/A |
| 3/31/2023 | 69 | -114 | -120 | -75 | N/A |
| 12/31/2022 | 65 | -113 | -120 | -70 | N/A |
| 9/30/2022 | 69 | -102 | -113 | -69 | N/A |
| 6/30/2022 | 76 | -94 | -97 | -72 | N/A |
| 3/31/2022 | 80 | -81 | -90 | -70 | N/A |
| 12/31/2021 | 85 | -65 | -82 | -71 | N/A |
| 9/30/2021 | 85 | -58 | -66 | -58 | N/A |
| 6/30/2021 | 83 | -50 | -63 | -56 | N/A |
| 3/31/2021 | 80 | -45 | -49 | -46 | N/A |
| 12/31/2020 | 79 | -41 | -46 | -43 | N/A |
| 9/30/2020 | 77 | -35 | -42 | -38 | N/A |
| 6/30/2020 | 74 | -32 | -38 | -31 | N/A |
| 3/31/2020 | 70 | -29 | -34 | -27 | N/A |
| 12/31/2019 | 65 | -25 | -26 | -18 | N/A |
| 9/30/2019 | 60 | -22 | -24 | -17 | N/A |
| 6/30/2019 | 55 | -19 | -13 | -8 | N/A |
| 3/31/2019 | 48 | -20 | -3 | 5 | N/A |
| 12/31/2018 | 38 | -20 | -2 | 6 | N/A |
| 12/31/2017 | 9 | -24 | -5 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PSNL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PSNL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PSNL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PSNL's revenue (21.9% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: PSNL's revenue (21.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PSNL is forecast to be unprofitable in 3 years.